Citadel Advisors’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Citadel Advisors’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-3,500	Closed	-$2K	–	9691
2015 Q3	$2K	Buy	+3,500	New	+$2K	﹤0.01%	8770
2014 Q4	–	Sell	-3,300	Closed	-$2K	–	8972
2014 Q3	$2K	Sell	3,300 -800	-20%	-$1.01K	﹤0.01%	8021
2014 Q2	$5K	Buy	+4,100	New	+$5.87K	﹤0.01%	7749

Other funds holding ONCY

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

KWMG

King Wealth Management Group Naples, Florida $800M AUM 22.41% 1-Year Est. Return

Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

Citadel Advisors's ONCY Position: Q4 2015 in Review

Citadel Advisors sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 38,262 shares — an estimated $18K sold.

Citadel Advisors first reported a position in ONCY in Q2 2014 and held it in 4 quarters. The position peaked at $20K in Q4 2014. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

Citadel Advisors reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
Citadel Advisors sold 38,262 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $18K.
Citadel Advisors first reported a position in ONCOLYTICS BIOTECH INC in Q2 2014 and held it in 4 quarters.
Citadel Advisors's ONCOLYTICS BIOTECH INC position peaked at $20K in Q4 2014.
7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Citadel Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.